Aramark 4Q Sales Rise Amid New Contracts

Dow Jones
2025/11/17

By Nicholas G. Miller

 

$Aramark(ARMK-W)$ reported higher fourth-quarter sales and said it was onboarding an "unprecedented level of new business."

The company posted net income of $87.2 million, down from $122.3 million the year before. On a per-share basis, earnings were 33 cents a share, down from 46 cents a share the year prior.

Adjusted earnings were 57 cents a share. Analysts expected 64 cents, according to FactSet.

The company said its profit was dragged down by additional incentive-based compensation tied to its new contracts.

Sales rose 14% to $5.05 billion. Wall Street expected $5.16 billion.

The company guided for fiscal 2026 revenue of $19.55 billion to $19.95 billion and adjusted earnings of $2.18 to $2.28 a share. Analysts see 2026 adjusted earnings of $2.27 a share and revenue of $19.69 billion.

In October, the company was picked for a systemwide contract by Penn Medicine, which analysts said would support significant revenue growth beginning in fiscal 2026.

Aramark also increased its quarterly dividend by 14% to 12 cents a share.

 

Write to Nicholas G. Miller at nicholas.miller@wsj.com.

 

(END) Dow Jones Newswires

November 17, 2025 06:54 ET (11:54 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10